Cargando…
Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individua...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817878/ https://www.ncbi.nlm.nih.gov/pubmed/20148089 http://dx.doi.org/10.2174/1874613601004020028 |
_version_ | 1782177255639744512 |
---|---|
author | Castelli, Francesco Pietra, Virginio Diallo, Ismael Schumacher, Richard F. Simpore, Jacques |
author_facet | Castelli, Francesco Pietra, Virginio Diallo, Ismael Schumacher, Richard F. Simpore, Jacques |
author_sort | Castelli, Francesco |
collection | PubMed |
description | Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individual, (●) stigma, (●) lack of qualified human resources and infrastructure, especially in the rural setting, (●) rescue drugs for failing patients and (●) pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include: (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users’ fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along. |
format | Text |
id | pubmed-2817878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-28178782010-02-10 Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? Castelli, Francesco Pietra, Virginio Diallo, Ismael Schumacher, Richard F. Simpore, Jacques Open AIDS J Article Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individual, (●) stigma, (●) lack of qualified human resources and infrastructure, especially in the rural setting, (●) rescue drugs for failing patients and (●) pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include: (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users’ fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along. Bentham Open 2010-01-19 /pmc/articles/PMC2817878/ /pubmed/20148089 http://dx.doi.org/10.2174/1874613601004020028 Text en © Castelli et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Castelli, Francesco Pietra, Virginio Diallo, Ismael Schumacher, Richard F. Simpore, Jacques Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? |
title | Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? |
title_full | Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? |
title_fullStr | Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? |
title_full_unstemmed | Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? |
title_short | Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? |
title_sort | antiretroviral (arv) therapy in resource poor countries: what do we need in real life? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817878/ https://www.ncbi.nlm.nih.gov/pubmed/20148089 http://dx.doi.org/10.2174/1874613601004020028 |
work_keys_str_mv | AT castellifrancesco antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife AT pietravirginio antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife AT dialloismael antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife AT schumacherrichardf antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife AT simporejacques antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife |